已收盘 09-25 16:00:00 美东时间
+0.190
+1.33%
今日重点评级关注:Ascendiant Capital:维持SurgePays"买入"评级,目标价从3.5美元升至3.75美元;HC Wainwright & Co.:维持Spero Therapeutics"买入"评级,目标价从5美元升至6美元
09-15 15:30
UBS analyst Arpine Kocharyan maintains Callaway Golf (NYSE:CALY) with a Neutral and lowers the price target from $19 to $17.
09-15 03:57
今日重点评级关注:BTIG:维持Kazia Therapeutics"买入"评级,目标价从34美元升至40美元;摩根大通:维持Annexon"超配"评级,目标价从10美元升至14美元
09-02 14:07
Truist Securities analyst Gregory Miller maintains Callaway Golf (NYSE:CALY) with a Buy and raises the price target from $19 to $20.
09-01 23:56
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
Keybanc analyst Noah Zatzkin maintains Callaway Golf (NYSE:CALY) with a Overweight and raises the price target from $19 to $22.
08-05 22:36
Callaway Golf (NYSE:CALY) sees Q3 sales of $415.000 million-$435.000 million vs $428.453 million analyst estimate.
08-05 04:23
Callaway Golf (NYSE:CALY) raises FY2026 sales outlook from $2.015 billion-$2.070 billion to $2.045 billion-$2.070 billion vs $2.066 billion estimate.
08-05 04:22
Callaway Golf (NYSE:CALY) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.35 by 11.11 percent. This is a 66.67 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $612.200 million whi...
08-05 04:19
今日重点评级关注:杰富瑞:上调Tango Therapeutics评级至"买入",目标价从27美元升至60美元;Susquehanna:维持安森美半导体"积极"评级,目标价从120美元升至140美元
06-29 15:49